Analyst firms · Wolfe Research · CARR
Wolfe Research CARR price target and rating history
Carrier Global Corporation (CARR) · Industrials
Wolfe Research rates Carrier Global Corporation (CARR) Outperform with a $80 price target, as of its latest action on Feb 24, 2025. It has published 4 rating actions on CARR since September 2021, including 2 upgrades and 2 downgrades. Across 5 firms with a CARR price target in the last 12 months, the median target is $67.
- Current rating
- Outperform
- Price target
- $80
- Median target, all firms
- $67
- Actions on CARR
- 4
Wolfe Research price target on CARR
Every Wolfe Research rating on CARR
- Feb 24, 2025
- Sep 6, 2024
- Oct 12, 2023
- Sep 7, 2021
How other firms rate CARR
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Goldman Sachs | Neutral | $61 | Oct 14, 2026 |
| Wells Fargo | Overweight | $67 | Sep 25, 2026 |
| Bernstein | Mkt Perform | $75 | Jun 10, 2026 |
| BNP Paribas Exane | Neutral | $62 | Apr 14, 2026 |
| Evercore ISI | Outperform | $75 | Apr 13, 2026 |
Questions about Wolfe Research and CARR
- What is Wolfe Research's price target for CARR?
- Wolfe Research's latest stated price target for Carrier Global Corporation (CARR) is $80, from its action on Feb 24, 2025.
- What is Wolfe Research's rating on CARR?
- Wolfe Research rates CARR Outperform, a bullish rating, as of Feb 24, 2025.
- When did Wolfe Research last change its view on CARR?
- On Feb 24, 2025, Wolfe Research upgrades to Outperform from Peer Perform, price target $80.
- How does Wolfe Research's CARR target compare with other analysts?
- Across 5 firms with a CARR price target in the last 12 months, the median target is $67.
More CARR rating histories
- Wells Fargo3
- Oppenheimer3
- Mizuho5
- Morgan Stanley6
- BofA Securities3
- Robert W. Baird3
- Citigroup3
- Deutsche Bank5
- Credit Suisse3
All Wolfe Research ratingsCARR news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.